Vitamin D and its binding protein in patients with leiomyomas
Journal of Obstetrics and Gynaecology Research · 2024
DOI: 10.1111/jog.15883 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Obstetrics and Gynaecology Research, 2024. Verfasst von Zeinab Latifi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Nervous system stem cell research center, Semnan University of Medical Sciences, Semnan, Iran. Hauptthemen laut MEDLINE: Leiomyoma, Vitamin D Deficiency. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Student's research committee of Arak University of Medical Sciences.
Abstract (Originalsprache)
Aim
This study examined the levels of VitD, VitD binding protein (DBP), and free VitD in leiomyomas patients and their association with the quantity, dimensions, and site of fibroid growths. Additionally, we evaluated the potentiality of employing these factors as a biomarker tool for the diagnosis and assessment of uterine fibroid progression.
Methods
This study involved the participation of 55 women with leiomyomas and 50 healthy women. We utilized commercial ELISA kits to measure the levels of total VitD and DBP in their serum. Additionally, we calculated the levels of free VitD and the ratio of VitD to DBP. Moreover, we determined the number, size, and location of the leiomyomas in the patients.
Results
There were no significant differences in the levels of total VitD between the groups. However, patients had significantly lower levels of free VitD and higher levels of DBP compared to the control group. The size of the largest leiomyomas showed a negative relationship with free VitD and a positive relationship with DBP. Receiver operating characteristic analyses, showed that the cut‐off value for free VitD was 4.47 pg/mL, with a sensitivity of 75.6% and a specificity of 74.4%. The cut‐off value for DBP was 256.2 μg/mL, with a sensitivity of 86% and a specificity of 70.3%.
Conclusions
Free VitD and DBP potentially contribute to the development of leiomyomas and are linked to the size of these tumors. The measurement of serum levels of these factors could serve as additional biomarkers for the diagnosis of leiomyomas.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nervous system stem cell research center, Semnan University of Medical Sciences, Semnan, Iran.
- Healthy Ageing Research Center, Neyshabur University of Medical Sciences, Neyshabur, Iran.
- Department of Biochemistry, Arak University of Medical Sciences, Arak, Iran.
- Students Research Committee, Arak University of Medical Sciences, Arak, Iran.
- Department of Reproductive Biology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
- Women's Reproductive Health Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
ORCID-Profile: Amir Fattahi
Förderung
- Student's research committee of Arak University of Medical Sciences
Zitieren
APA
Latifi, Z., Oghbaei, F., Salemi, Z., Kamalipoya, S., & Fattahi, A. (2024). Vitamin D and its binding protein in patients with leiomyomas. Journal of Obstetrics and Gynaecology Research. https://doi.org/10.1111/jog.15883
Vancouver
Latifi Z, Oghbaei F, Salemi Z, Kamalipoya S, Fattahi A. Vitamin D and its binding protein in patients with leiomyomas. Journal of Obstetrics and Gynaecology Research. 2024. doi:10.1111/jog.15883
BibTeX
@article{Latifi2024,
author = {Latifi, Zeinab and Oghbaei, Farnaz and Salemi, Zahra and Kamalipoya, Samaneh and Fattahi, Amir},
title = {Vitamin D and its binding protein in patients with leiomyomas},
journal = {Journal of Obstetrics and Gynaecology Research},
year = {2024},
doi = {10.1111/jog.15883}
}
EUVIMED